Barbara Troupin
Director/Board Member at EQUILLIUM, INC.
Net worth: - $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Bradbury | M | 62 | 7 years | |
| Bruce Steel | M | 57 | 7 years | |
| Stephen Connelly | M | 42 | 7 years | |
| Bala S. Manian | M | 77 | 7 years | |
| Yu Katherine Xu | M | 52 | 3 years | |
| Michael Moore | M | - | 4 years | |
| Mark Pruzanski | M | 56 | 6 years | |
| Jeffrey Galik | M | - | 4 years | |
| Elizabeth Mily | F | 56 | 4 years | |
| Martha Demski | F | 71 | 6 years | |
| Charles McDermott | M | 52 | 6 years | |
| Sophia Park | F | - | 4 years | |
| Maple Fung | M | - | 4 years | |
| Cherie Ng | F | - | - | |
| Matthew R. Ritter | M | - | - | |
| Christine Zedelmayer | F | 54 | 6 years | |
| Katherine Reynolds Kelly | F | 48 | 4 years | |
| Joel Rothman | M | 55 | 6 years | |
| Brian Heaphy | M | - | 4 years | |
| Lisa Goldey | F | - | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Timothy Morris | M | 62 | 9 years | |
| Mark B. Logan | M | 84 | 15 years | |
| Robert Wilson | M | 83 | 1 years | |
| Peter Y. Tam | M | 60 | 20 years | |
| Michael Astrue | M | 67 | 1 years | |
| David Norton | M | 72 | 7 years | |
| Kim Popovits | F | 65 | 3 years | |
| Seth Fischer | M | 68 | 4 years | |
| Mary Cranston | F | 76 | 4 years | |
| David Meeker | M | 69 | 3 years | |
| Kelvin Neu | M | 50 |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 2 years |
| Shelley McCloskey | F | 64 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 3 years |
| John L. Slebir | M | 58 | 12 years | |
| Leland F. Wilson | M | 80 | 22 years | |
| Charles H. Bowden | M | - | - | |
| Sunil Agarwal | M | 54 | 4 years | |
| Herm Rosenman | M | 76 | - | |
| Johannes J. P. Kastelein | M | 70 | 2 years | |
| Svai Sanford | M | 54 | 3 years | |
| Michelle Corral | F | - | 4 years | |
| Catherine Bovenizer | F | 52 |
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 1 years |
| June Lee | M | 58 | 3 years | |
| Dolca Thomas | M | 53 | 1 years | |
| Denelle Waynick | F | 57 | - | |
| Richard Levy | M | 66 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 2 years |
| Anthony Zook | M | 63 | - | |
| Wendy Yarno | F | 68 | 3 years | |
| Alexander Denner | M | 54 | 2 years | |
| Jorge Plutzky | M | 65 | - | |
| Sam Colin | M | 59 | 2 years | |
| Robert McDowell | M | 66 | 8 years | |
| Ernest Mario | M | 85 | 1 years | |
| J. Carroll | M | 74 | 1 years | |
| Deirdre Y. Gillespie | M | 67 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | 6 years |
| Mark Perry | M | 68 | 8 years | |
| Linda M. Dairiki Shortliffe | M | 75 | 14 years | |
| Virgil A. Place | M | 99 | 19 years | |
| Charles Casamento | M | 78 | 5 years | |
| Jay Edelberg | M | - | - | |
| Michael Miller | M | 67 | 4 years | |
| Ted Broman | M | - | - | |
| John Dietrich | M | 77 | 7 years | |
| William Fairey | M | 60 | 1 years | |
| Brooks Rahmer | M | - | 2 years | |
| David Mitchell | M | 67 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 3 years |
| Jessica Stitt | F | 47 | 1 years | |
| Jason Keyes | M | 53 | 6 years | |
| Christopher Thompson | M | - | - | |
| Malcolm McKay | M | - | - | |
| Santosh T. Varghese | M | 53 | - | |
| Alfred Tenuto | M | - | - | |
| Preston Klassen | M | 55 | - | |
| Joseph Lambing | M | - | 1 years | |
| Sandra E. Wells | M | - | - | |
| Mario Rosati | M | 77 | 9 years | |
| Jake Bauer | M | 45 | 6 years | |
| Chang Jin Wang | M | 66 | - | |
| Paul Brennan | M | - |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | 2 years |
| Taylor Harris | M | 48 | 2 years | |
| Cynthia J. Ladd | F | 68 | 3 years | |
| Graham Strachan | M | 85 | 9 years | |
| Lee B. Perry | M | 73 | 8 years | |
| Holly Schachner | M | 57 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 78 | 93.98% |
| Canada | 5 | 6.02% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barbara Troupin
- Personal Network
